drugset / Trial / NCT01226615

Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)

NCT01226615

Phase 4 Unknown 64 enrolled Bioiberica
RandomizedParallel-groupTriple-blindTreatment

Summary

The main purposes of this study are: * to determine the effects of chondroitin sulphate on brain response to pain assessed through fMRI in patients with knee osteoarthritis. * to investigate the relationship between treatment response detected by fMRI and the results of the different parameters of clinical assessment.

Timeline

Start
2010-10
Primary completion
2011-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulphate Unknown 800 mg

Indications